The UroLift® System is a new, minimally invasive approach to treating BPH for patients looking for an alternative to drug therapy or more invasive surgery. The UroLift System is a straightforward procedure that utilizes tiny implants to lift and hold the enlarged prostate tissue out of the way so it no longer blocks the urethra. There is no cutting, heating or removal of prostate tissue.
The UroLift System is clinically proven to be safe and effective and provides rapid symptom relief.2 Typically, the procedure is done in the physician's office under local anesthesia and does not require a catheter to be placed. A unique benefit of the UroLift System is that it preserves a man's sexual function.1 The goal is to relieve you of bothersome urinary symptoms so you can get back to your life and resume daily activities.
Clinical studies have demonstrated that the UroLift procedure provides a similar level of symptom relief (compared with other BPH procedures), with fewer side effects.2 Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.
For more information about UroLift System treatment, contact us or click here for frequently asked questions.
An enlarged prostate compresses on the urethra, making it difficult for urine to flow.
The UroLift Device is placed through the obstructed urethra to access the enlarged prostate.
The device compresses the tissue and delivers tiny implants to lift and hold prostate tissue out of the way, thus opening the urethra. The permanent implants keep the tissue in place, like tiebacks on a window curtain.
The UroLift Device is removed, leaving an open urethra for urine to flow.
To view a video animation of the UroLift® System treatment, please click on the play button.
Learn about the UroLift experience from an actual patient.
1. AUA Guidelines 2003
2. Roehrborn et al., Canadian Journal of Urology 2015, 3-Year L.I.F.T. Study Results
© 2015 NeoTract, Inc. All Rights Reserved. MAC00181-01 Rev C